Language selection

Search

2006-09-07 - Male

207594

Adverse reaction report number 207594
Latest AER version number 0
Market authorization holder AER number SPV1200600630
Initial received date 2006-09-07
Latest received date 2006-09-07
Age N/A
Gender Male
Weight N/A
Type of report Spontaneous
Reporter type Physician
Source of report MAH
Report outcome Recovered/resolved
Serious report? No

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral10 Milligram1 Year(s)
REACTINENOT SPECIFIEDConcomitantUnknown

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Alopecia
Date modified: